$1.130
-0.184 (-16.30%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
PPCB 相似图表分析预测
Alphio's PPCB stock price prediction model matches the current Propanc Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (-0.49%). The 1-week path is $1.07 (-5.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Propanc Biopharma Inc 股票吗？
Propanc Biopharma Inc (PPCB) appears to be a good buy right now due to its recent surge of 202.75% after reporting significant tumor growth inhibition of over 90% in advanced pancreatic cancer models. Additionally, the stock has shown a 25% increase over the last five days, indicating positive momentum. However, the main risk is its year-to-date change of -90.55%, suggesting high volatility and potential for further declines if the positive news does not sustain investor interest.
PPCB 股价于 Tuesday 收于 $1.13，此前下跌 -16.30%
Propanc Biopharma Inc (PPCB) last closed at $1.13, losing -16.30%. These facts feed the 1-day and 1-week PPCB price prediction above.
预测驱动因素
Propanc Biopharma Inc（PPCB）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 PPCB 最接近的股票，按相似度排序。
PPCB 季节性分析
Historically the probability of a positive September return for PPCB is 0.00%. August offers the highest probability of a positive month at 31.25%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。